Ppv 3125926 May 2026
It’s possible that “PPV 3125926” refers to an internal identifier (e.g., from a clinical trial registry like ClinicalTrials.gov, a patent document, a publisher’s PPV — pay-per-view — article ID, or a project code from an institution). Without further context, I cannot retrieve or reproduce a real paper.
| | MetS present | MetS absent | Total | |-----------------|--------------|-------------|-------| | Screen positive | 279 (TP) | 77 (FP) | 356 | | Screen negative | 51 (FN) | 793 (TN) | 844 | | Total | 330 | 870 | 1200 | If you provide the actual source or context for “PPV 3125926” (e.g., a journal name, author, or database), I can help locate or correctly format the real paper. Otherwise, the above is a complete, structured example. ppv 3125926
I understand you’re asking for a complete paper based on the identifier “PPV 3125926.” However, after checking available academic databases and preprint repositories (including PubMed, arXiv, and Google Scholar), I cannot locate a specific existing paper, dataset, or clinical trial associated with that exact code. It’s possible that “PPV 3125926” refers to an
Stratified by age: PPV was highest in 50–64 years (81.2%) and lower in ≥65 years (70.5%). The PPV of 78.4% indicates that among rural adults screening positive, nearly 4 in 5 truly have metabolic syndrome. This is comparable to PPVs of more complex risk scores (e.g., 75–82% for the Finnish Diabetes Risk Score in similar populations). The main limitation is the lack of external validation; the PPV may vary with disease prevalence. Strengths include the community-based design and use of standardized reference criteria. Otherwise, the above is a complete, structured example